147 related articles for article (PubMed ID: 37099088)
21. Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study.
McLaren AS; Spoor JA; Cartwright D; Naylor G; Barclay S; Priest M; Puttagunta S; Armstrong K; Ballantyne S; Stanley A; Jeffry Evans TR;
BMJ Open Gastroenterol; 2023 Nov; 10(1):. PubMed ID: 37989352
[TBL] [Abstract][Full Text] [Related]
22. Survival Impact of Time to Initiation of Adjuvant Radiation for Merkel Cell Carcinoma: An Analysis of the National Cancer Database.
Yusuf M; Gaskins J; Tennant P; Bumpous J; Dunlap N
Pract Radiat Oncol; 2019; 9(4):e372-e385. PubMed ID: 30926480
[TBL] [Abstract][Full Text] [Related]
23. Shorter Time to Treatment Is Associated With Improved Survival in Rural Patients With Breast Cancer Despite Other Adverse Socioeconomic Factors.
Nguyen MT; Wei W; Cooper G; Khorana AA; Kamath S
Oncology (Williston Park); 2023 Jan; 37(1):19-24. PubMed ID: 36724138
[TBL] [Abstract][Full Text] [Related]
24. Does race affect management and survival in hepatocellular carcinoma in the United States?
Hoehn RS; Hanseman DJ; Wima K; Ertel AE; Paquette IM; Abbott DE; Shah SA
Surgery; 2015 Nov; 158(5):1244-51. PubMed ID: 25958069
[TBL] [Abstract][Full Text] [Related]
25. Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis.
Yang JD; Luu M; Singal AG; Noureddin M; Kuo A; Ayoub WS; Sundaram V; Kotler H; Kim IK; Todo T; Voidonikolas G; Brennan TV; Kosari K; Klein AS; Hendifar A; Lu SC; Nissen NN; Gong J
J Natl Compr Canc Netw; 2020 Sep; 18(9):1210-1220. PubMed ID: 32886898
[TBL] [Abstract][Full Text] [Related]
26. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
27. Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis.
Ramey SJ; Rich BJ; Kwon D; Mellon EA; Wolfson A; Portelance L; Yechieli R
J Gastrointest Oncol; 2018 Dec; 9(6):1109-1126. PubMed ID: 30603130
[TBL] [Abstract][Full Text] [Related]
28. Time to Diagnosis and Treatment Initiation During the COVID-19 Pandemic Among Rural Patients With Cancer.
Okado I; Liu M; Elhajj C; Hernandez BY; Wilkens L; Holcombe RF
Asia Pac J Public Health; 2024 May; 36(4):387-390. PubMed ID: 38553966
[TBL] [Abstract][Full Text] [Related]
29. Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation.
Frosch ZAK; Illenberger N; Mitra N; Boffa DJ; Facktor MA; Nelson H; Palis BE; Bekelman JE; Shulman LN; Takvorian SU
JAMA Netw Open; 2021 Jul; 4(7):e2115675. PubMed ID: 34241630
[TBL] [Abstract][Full Text] [Related]
30. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey.
Zhao H; Zhou A; Zhou J; Bi X; Yan S; Jin J; Wei W; Li M; Gong C; Chen Q; Luo Z; Li N; Mao R; Chen X; Chen B; Zheng R; Zhao J; Han Y; Li Z; Che X; Tang Y; Sun Y; Huang Z; Zhang Y; Wang X; Zhang Y; Lu Z; Dang X; Song T; Liu C; Yue P; Yan D; Yue A; Zhang R; Luo S; Tan J; Zhang X; Bai X; Zhang X; He M; Xie Y; Wang W; Yang P; Yang Y; Zhang Y; Li Q; Peng T; Wang Z; Chen Y; Shang C; Liang Y; Zhang B; Zhang F; Wang L; Li D; Liu B; Zhu X; Hu Q; Chen M; Xiu D; Xia F; Zhang Y; Zeng Y; Mao Y; Li X; Ba Y; Liang T; Shen F; Liu L; Cai X; Zhou J; Cai J
HPB (Oxford); 2022 Mar; 24(3):342-352. PubMed ID: 34400051
[TBL] [Abstract][Full Text] [Related]
31. Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic.
Hawrot K; Shulman LN; Bleiweiss IJ; Wilkie EJ; Frosch ZAK; Jankowitz RC; Laughlin AI
JCO Oncol Pract; 2021 Sep; 17(9):534-540. PubMed ID: 33710914
[TBL] [Abstract][Full Text] [Related]
32. Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study.
Jensen JS; Jakobsen KK; Mirian C; Ghanizada M; Håkansson K; Wessel I; Grønhøj C; Rasmussen JH; von Buchwald C
Acta Oncol; 2021 Apr; 60(4):491-496. PubMed ID: 33356698
[TBL] [Abstract][Full Text] [Related]
33. Predictive Factors for Cancer Treatment Delay in a Racially Diverse and Socioeconomically Disadvantaged Urban Population.
Sheni R; Qin J; Viswanathan S; Castellucci E; Kalnicki S; Mehta V
JCO Oncol Pract; 2023 Jun; 19(6):e904-e915. PubMed ID: 37001038
[TBL] [Abstract][Full Text] [Related]
34. Effects of time to treatment initiation on outcomes for soft tissue sarcomas.
Ryu JH; Rahman J; Deo S; Flint M
J Surg Oncol; 2023 Jun; 127(7):1174-1186. PubMed ID: 36939055
[TBL] [Abstract][Full Text] [Related]
35. The Impact of Medicaid Expansion on Early-Stage Hepatocellular Carcinoma Care.
Lima HA; Endo Y; Moazzam Z; Alaimo L; Dillhoff M; Kim A; Beane J; Ejaz A; Cloyd J; Resende V; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4589-4599. PubMed ID: 37142835
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of time trends in treatment of head and neck squamous cell carcinoma.
Balchander D; Shorbaji K; Cabrera CI; Hoying D; Clancy K; Fowler N; Thuener JE; Lavertu P; Pan Q; Teknos TN; Rezaee RP; Li S; Tamaki A
Am J Otolaryngol; 2023; 44(6):103966. PubMed ID: 37481899
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
Uhlig J; Sellers CM; Stein SM; Kim HS
Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
[TBL] [Abstract][Full Text] [Related]
38. Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study.
Kronenfeld JP; Ryon EL; Goldberg D; Lee RM; Yopp A; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Russell MC; Livingstone AS; Merchant NB; Goel N
Ann Surg Oncol; 2021 Apr; 28(4):1929-1936. PubMed ID: 32975686
[TBL] [Abstract][Full Text] [Related]
39. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.
Zhang X; El-Serag HB; Thrift AP
Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207
[TBL] [Abstract][Full Text] [Related]
40. Predictors of time to definitive surgery and survival in Merkel cell carcinoma: analysis of the US National Cancer Database.
Desai AD; Behbahani S; Samie FH
Clin Exp Dermatol; 2022 Jul; 47(7):1275-1282. PubMed ID: 35150153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
